STOCK TITAN

Beyond Air (NASDAQ: XAIR) sells stock, warrants in $5M deal

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Beyond Air, Inc. entered into a private placement with an institutional investor, agreeing to sell 524,990 common shares at $1.272 per share, pre-funded warrants to purchase up to 3,405,828 shares at $1.2719 per warrant, and common warrants to purchase up to 3,930,818 shares, for aggregate gross proceeds of $5,000,000. The pre-funded warrants have a nominal exercise price of $0.0001 per share and the common warrants have an exercise price of $1.147 per share and expire on January 16, 2031. The company agreed to register the resale of the shares and warrant shares by filing a registration statement by February 4, 2026, with effectiveness targeted within 60 to 90 days after January 14, 2026, and may owe liquidated damages if these deadlines are missed. Beyond Air will pay Rodman & Renshaw LLC a cash fee of 7% of gross proceeds and reimburse up to $50,000 of expenses and is subject to specified restrictions on additional equity issuances and variable rate transactions for defined periods.

Positive

  • None.

Negative

  • None.

Insights

Beyond Air raises $5M via a structured equity and warrant private placement.

Beyond Air, Inc. is raising $5,000,000 in gross proceeds through a private placement of 524,990 common shares plus pre-funded and common warrants. Pre-funded warrants cover up to 3,405,828 shares at a nominal exercise price of $0.0001, and common warrants cover up to 3,930,818 shares at an exercise price of $1.147 per share, both exercisable immediately.

The transaction includes a 4.99% beneficial ownership cap on warrant exercises, which limits any single holder’s post-exercise stake at one time. The common warrants expire on January 16, 2031 and may be exercised on a cashless basis if a resale registration is not effective, which can influence whether the company receives additional cash from exercises.

The company must file a resale registration statement by February 4, 2026 and have it declared effective within 60 or 90 days after January 14, 2026, or pay liquidated damages if it fails to meet these milestones. Until 90 days after the registration statement becomes effective, and for six months after closing in the case of variable rate transactions, Beyond Air agreed to restrictions on additional equity or variable-rate financings, which shapes near-term financing flexibility.

false 0001641631 0001641631 2026-01-14 2026-01-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): January 14, 2026

 

Beyond Air, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-38892   47-3812456

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

900 Stewart Avenue, Suite 301

Garden City, NY 11530

(Address of Principal Executive Offices and Zip Code)

 

(516) 665-8200

Registrant’s Telephone Number, Including Area Code

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $.0001 per share   XAIR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry Into a Material Definitive Agreement.

 

On January 14, 2026, Beyond Air, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor. Pursuant to the Purchase Agreement, the Company agreed to sell to the investor, and the investor agreed to purchase from the Company, in a private placement offering, an aggregate of (i) 524,990 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $1.272 per Share, (ii) pre-funded warrants to purchase up to 3,405,828 shares of Common Stock (the “Pre-funded Warrants”) at a purchase price of $1.2719 per Pre-funded Warrant and (iii) warrants to purchase up to 3,930,818 shares of Common Stock (the “Common Warrants”, and together with the Pre-funded Warrants the “Warrants”), for aggregate gross proceeds under the Purchase Agreement of $5,000,000. Each Share and each Pre-funded Warrant was sold with an accompanying Common Warrant to purchase one share of Common Stock. The Pre-funded Warrants have an exercise price of $0.0001 per share, and the Common Warrants have an exercise price of $1.147 per share. The offering closed on January 16, 2026 (the “Closing Date”), on satisfaction of customary closing conditions.

 

The Pre-funded Warrants are exercisable immediately upon issuance and shall expire when exercised in full. The Common Warrants are exercisable immediately upon issuance and expire on January 16, 2031, if not fully exercised. The Common Warrants are exercisable on a cashless basis in the event that, at the time of exercise, there is not an effective registration statement for the resale of the shares underlying the Common Warrants. The respective Pre-funded Warrants or Common Warrants may not be exercised to the extent such exercise would cause the holder to beneficially own more than 4.99% of the Company’s issued and outstanding Common Stock. The exercise price of the Warrants is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events and also upon any distributions of assets, including cash, stock or other property to our stockholders.

 

Pursuant to the Purchase Agreement, for a period commencing upon the signing of the Purchase Agreement, until 90 days after the effective date of the Registration Statement, neither the Company nor any of its subsidiaries shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or common stock equivalents, or (ii) file any registration statement or any amendment or supplement thereto. The restrictions are subject to certain exceptions as described in the Purchase Agreement. Further, for a period of six months following the closing date, Company is also prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction, as defined in the Purchase Agreement.

 

In connection with the Purchase Agreement, on January 14, 2026, the Company also entered into a registration rights agreement (the “Registration Rights Agreement”) with the investor. Pursuant to the Registration Rights Agreement, the Company will be required to file a resale registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) to register for resale of the Shares and the shares of common stock underlying the Warrants. The Company agreed to file the Registration Statement by February 4, 2026, and to have such Registration Statement declared effective within 60 days after January 14, 2026, or 90 days after January 14, 2026 in the event of a “full review” by the SEC. The Company will be obligated to pay liquidated damages to the investors if the Company fails to file the Registration Statement when required or fails to cause the Registration Statement to be declared effective by the SEC when required.

 

 

 

 

The Shares, Pre-funded Warrants and Common Warrants (and the shares of Common Stock underlying the Warrants) were not registered under the Securities Act of 1933, as amended (the “Securities Act”), and were offered pursuant to an exemption from the registration requirements of the Securities Act provided under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated under the Securities Act.

 

On January 14, 2026, in connection with the private placement offering, the Company entered into a Placement Agency Agreement with Rodman & Renshaw LLC. The Company will pay the placement agent an aggregate cash fee equal to 7.0% of the gross proceeds of the private placement offering and agreed to reimburse the placement agents for all reasonable out-of-pocket expenses, not exceeding $50,000 in aggregate.

 

The foregoing descriptions of the Purchase Agreement, Pre-funded Warrants, Common Warrants, Registration Rights Agreement and the Placement Agency Agreement do not purport to be complete and are subject to, and qualified in their entirety by reference to the full text of such documents which are attached as exhibits to this Form 8-K, and are incorporated herein by reference.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information provided in response to Item 1.01 of this report is incorporated by reference into this Item 3.02.

 

Item 8.01 Other Events

 

On January 14, 2026, the Company issued a press release to announce the private placement offering described above in Item 1.01. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
4.1   Form of Pre-funded Warrant
4.2   Form of Common Warrant
10.1   Form of Securities Purchase Agreement
10.2   Form of Registration Rights Agreement
10.3   Form of Placement Agency Agreement
99.1   Press Release from Beyond Air, Inc., dated as of January 14, 2026.
104   Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BEYOND AIR, Inc.
     
Date: January 20, 2026 By: /s/ Steven A. Lisi
  Name: Steven A. Lisi
  Title: Chief Executive Officer

 

 

FAQ

What did Beyond Air (XAIR) announce in this 8-K filing?

Beyond Air, Inc. disclosed that on January 14, 2026 it entered into a securities purchase agreement with an institutional investor for a private placement of common stock, pre-funded warrants and common warrants, providing aggregate gross proceeds of $5,000,000.

How much capital is Beyond Air (XAIR) raising and on what terms?

The company agreed to sell 524,990 common shares at $1.272 per share, pre-funded warrants to purchase up to 3,405,828 shares at $1.2719 per pre-funded warrant, and common warrants to purchase up to 3,930,818 shares of common stock, for total gross proceeds of $5,000,000.

What are the key terms of Beyond Air’s pre-funded and common warrants?

The pre-funded warrants are exercisable immediately with an exercise price of $0.0001 per share and remain outstanding until fully exercised. The common warrants are also exercisable immediately, have an exercise price of $1.147 per share, and expire on January 16, 2031. Exercises are limited so the holder does not beneficially own more than 4.99% of outstanding common stock.

What registration rights did Beyond Air (XAIR) grant to the investor?

Beyond Air entered into a registration rights agreement requiring it to file a resale registration statement with the SEC by February 4, 2026 to cover the shares and warrant shares, and to have it declared effective within 60 days after January 14, 2026, or 90 days if the SEC conducts a full review, with liquidated damages payable if these deadlines are not met.

Are there restrictions on Beyond Air’s future equity issuances after this private placement?

Under the purchase agreement, from signing until 90 days after the resale registration statement becomes effective, Beyond Air and its subsidiaries may not issue or agree to issue common stock or equivalents or file related registration statements, subject to exceptions. In addition, for six months after closing, the company is prohibited from entering into equity issuances involving a Variable Rate Transaction as defined in the agreement.

How is the private placement being facilitated and what fees will Beyond Air pay?

On January 14, 2026, Beyond Air entered into a Placement Agency Agreement with Rodman & Renshaw LLC. The company will pay a cash fee equal to 7% of the $5,000,000 gross proceeds and reimburse the placement agent for reasonable out-of-pocket expenses up to $50,000.

Under what securities law exemption was Beyond Air’s offering conducted?

The common shares, pre-funded warrants, common warrants and underlying shares were not registered under the Securities Act of 1933 and were offered pursuant to exemptions under Section 4(a)(2) and/or Rule 506 of Regulation D.
Beyond Air Inc

NASDAQ:XAIR

XAIR Rankings

XAIR Latest News

XAIR Latest SEC Filings

XAIR Stock Data

15.62M
7.55M
11.57%
10.53%
6.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GARDEN CITY